Micap Group | Microencapsulation | Yeast 'up the nose' may save diabetic patients from the pain of injections

	News and articles
	2006

	5th July 2006g New Micap grant new option agreement for Nufarm Ltd

	19th May 2006 Release of Preliminary Results

	9th January 2006g Micap January Newsletter

2005
	22nd December 2005g Interim results for the six months to 30th September 2005

	18th November 2005g Notice of Annual General Meeting and Extraordinary General Meeting - Capital Reduction - Capital Reorganisation

	26th September 2005g Yeast 'up the nose' may save diabetic patients from the pain of injections

	21st September 2005 Preliminary announcement for the twelve months to 31st March 2005

	5th May 2005gg Newsletter Issue 2.3

	23rd February 2005gg Acquisition of Rendel & Scherer GbR ("R&S") for up to €1.0 million

2004
	20th October 2004 Micap encapsulated fungicides to improve control of fungal damage to cereal crops

	23rd Augustg2004 Micap announces option agreement with BioProgress plc

	17th August 2004 Skyepharma exercises option under agreement with micap

	8th July 2004 Commencement of clinical trials into MRSA

	1st June 2004 Global launch by flavour

	10th May 2004 Micap in joint agreement with Fertin

	1st March 2004 Grant of licence for pharmaceutical applications

	20th January 20th 2004 Research update

2003
	2003 August 7th Micap plc floats on AIM!

	2003 July 24th Intention to float on AIM

	2003 June 1st Flavour License Deal

	2003 May 1st SMART Award

	2003 January 13th Skye Pharma Investment

Release of Preliminary Results

Micap plc ("Micap" or the "Company") will release its preliminary results during the week commencing 5th June 2006 .

Contact: Micap plc 01942 625590
Michael Norris, CEO 07966 341802

About the Company

Micap is a provider of microencapsulation solutions to a range of customers in fields such as flavour delivery, agrochemicals, healthcare and industrial applications, using both its proprietary yeast cell technology and bespoke methods developed by its scientific team.